Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
absolute, Acknowledging, affirmed, agnostic, Allergy, appellant, arriving, BCMA, BCVA, biallelic, bid, bioreactor, Breininger, CAR, ChAd, charitable, Chinese, CHMP, circumvention, Citizenship, clearance, client, cloud, combat, compliant, condensed, consecutive, constantly, constraint, correlation, curative, dAMD, delegated, delisting, descendent, dismissed, DSCSA, DSMB, earliest, editing, endemic, endorsement, escalate, escalation, fashion, fight, fit, float, footnote, GA, harder, HRSA, immaterial, Kumar, LDNA, library, liMeliGhT, LLVA, Luminance, Lux, MAA, maker, male, Michael, misread, MLMT, mobility, monovalent, multifactorial, Navigation, NextGen, NIAID, noncash, nonsurgical, nurse, opportunistically, pivotal, prejudice, prioritize, proficiency, Ramesh, recalculated, recalculation, referenced, regain, regained, remeasure, remeasurement, rescinded, retrofitting, retrospectively, RIA, SAB, secondary, send, short, simplification, spray, standalone, statutorily, superseded, surgical, Task, TEA, Teamwork, top, unaudited, unconstrained, uniform, unwavering, vascular, vast, versatility, vialing, wider
Removed:
achieved, adjuvant, adsorbed, adulterated, Affordable, aggregating, agonist, Algel, alum, anatomy, antigen, asymptomatic, authoritative, bankrupt, began, blue, Book, borrow, breath, breathing, Cantor, card, collateralize, commenced, commerce, concentration, conclusion, conform, constituting, construct, contemporaneously, converted, convicted, cough, counterfeit, custody, deceive, deltoid, designing, dissolution, diverted, domain, electroretinogram, elicit, embezzling, entirety, ERG, escape, expressly, fatal, felony, fever, Fitzgerald, fluorescent, formulated, freedom, gave, GFP, green, histological, histology, humoral, illegal, immunogenicity, immunohistochemistry, immunostaining, inactivated, injected, insolvency, insolvent, interstate, IRD, issuing, layer, legality, levy, load, longevity, medication, memory, messenger, minimization, modified, molecule, month, mRNA, muscle, mutational, neutralization, nucleocapsid, null, obstructing, occurring, offense, ONL, opsin, Orange, outbreak, outer, overexpression, overpayment, panel, participant, pathogen, Paycheck, percent, phenotype, phosphodiesterase, photopic, phototransduction, pre, preissuance, preserved, proof, propiolactone, qualification, quarantine, ramped, reclassified, recognizing, red, refunded, releasing, rendered, rescued, researching, responding, restoring, resubmission, resubmitted, retention, revalued, revising, revoke, RNA, safely, scotopic, seize, signal, slowdown, smell, staining, stealing, stockpile, strain, stricter, suggesting, syndrome, taste, temperature, terminating, therefrom, thirty, titer, transitioning, trick, understated, unfit, unvested, urgent, vaccinated, varied, waiver, yielding
Filing tables
Filing exhibits
Related press release
Associated OCGN transcripts
OCGN similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1)Registration Statement (Form S-3 No. 333-234127) of Ocugen, Inc.,
(2)Registration Statement (Form S-8 No. 333-237454) pertaining to the Ocugen, Inc. 2019 Equity Incentive Plan and the Ocugen, Inc. 2014 Stock Option Plan,
(3)Registration Statement (Form S-8 No. 333-254549) pertaining to the Ocugen, Inc. 2019 Equity Incentive Plan,
(4)Registration Statement (Form S-8 No. 333-263063) pertaining to the Ocugen, Inc. Inducement Stock Option and Restricted Stock Unit Awards (June 2021 – February 2022),
(5)Registration Statement (Form S-8 No. 333-263064) pertaining to the Ocugen, Inc. 2019 Equity Incentive Plan,
(6)Registration Statement (Form S-8 No. 333-270082) pertaining to the Ocugen, Inc. Inducement Stock Option and Restricted Stock Unit Awards (March 2022 – September 2022), and
(7)Registration Statement (Form S-8 No. 333-270083) pertaining to the Ocugen, Inc. 2019 Equity Incentive Plan;
of our report dated April 16, 2024, with respect to the consolidated financial statements of Ocugen, Inc. included in this Annual Report (Form 10-K) of Ocugen, Inc. for the year ended December 31, 2023.
/s/ Ernst & Young LLP
Philadelphia, Pennsylvania
April 16, 2024